Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21609558 | 0.96 | LTA4H (0.32) | LTA4H | |
| SCHEMBL238216 | 0.79 | DUT (0.38) | TSHRLTA4HMEN1KMT2A | |
| SCHEMBL4855961 | 0.78 | NPSR1 (0.32) | LTA4H | |
| SCHEMBL646601 | 0.78 | LTA4H (0.31) | LTA4H | |
| SCHEMBL5078835 | 0.78 | LTA4H (0.31) | LTA4H | |
| SCHEMBL703379 | 0.77 | ESR1 (0.37) | TSHRLTA4HMEN1KMT2A | |
| SCHEMBL13621323 | 0.76 | ALDH1A1 (0.33) | TSHRLTA4H | |
| SCHEMBL3482014 | 0.74 | HPGD (0.39) | TSHRMEN1KMT2A | |
| SCHEMBL5080821 | 0.74 | CA4 (0.32) | TSHR | |
| SCHEMBL8639537 | 0.74 | L3MBTL1 (0.33) | TSHRLTA4HMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1906911-B1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE & TECH ORG (AU) | 2019-09-25 | — | — | EP | disclosed |
| US-9131681-B2 | Particles comprising a releasable dopant therein | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2015-09-15 | — | — | US | disclosed |
| US-9017643-B2 | Particles comprising a releasable dopant therein | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2015-04-28 | — | — | US | disclosed |
| US-20150004095-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | Encap Hive Pty Ltd (AU) | 2015-01-01 | — | — | US | disclosed |
| US-20140322326-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | Encap Hive Pty Ltd (AU) | 2014-10-30 | — | — | US | disclosed |
| US-8815291-B2 | Particles comprising a releasable dopant therein | Austrailian Nuclear Science & Technology Organisation (AU) | 2014-08-26 | — | — | US | disclosed |
| US-20080199523-A1 | Emulsion with hydrophilic, hydrophobic phase ; reacted in presence of catalyst; anticancer agents, aids, antiarthritic agents, antidiabetic agents, analgesics | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION | 2008-08-21 | — | — | US | disclosed |
| EP-1906911-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) | 2008-04-09 | — | — | EP | disclosed |
| WO-2006133519-A1 | PARTICLES COMPRISING A RELEASABLE DOPANT THEREIN | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) | 2006-12-21 | — | — | WO | disclosed |